NCT04981327View on ClinicalTrials.gov

The API-CALF Study: Apixaban to Treat Calf Vein Thrombosis

PHASE3Not yet recruitingINTERVENTIONAL
Enrollment

1,300

Participants

Timeline

Start Date

September 1, 2022

Primary Completion Date

August 31, 2026

Study Completion Date

August 31, 2027

Conditions
Deep Vein Thrombosis
Interventions
DRUG

Apixaban 2.5 MG Oral Tablet [ELIQUIS]

Apixaban 5 MG BID versus Apixaban 2.5 MG BID

All Listed Sponsors
collaborator

Sunnybrook Health Sciences Centre

OTHER

lead

University Hospital, Geneva

OTHER

NCT04981327 - The API-CALF Study: Apixaban to Treat Calf Vein Thrombosis | Biotech Hunter | Biotech Hunter